The Enterprise Value as of December 2025 (TTM) for TriSalus Life Sciences, Inc. (TLSI) is 232.79M

According to TriSalus Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 232.79M. This represents a change of 28.69% compared to the average of 180.90M of the last 4 quarters.

TriSalus Life Sciences, Inc. (TLSI) Historical Enterprise Value (quarterly & annually)

How has TLSI Enterprise Value performed in the past?

The mean historical Enterprise Value of TriSalus Life Sciences, Inc. over the last ten years is 258.44M. The current 232.79M Enterprise Value has changed 8.91% with respect to the historical average. Over the past ten years (40 quarters), TLSI's Enterprise Value was at its highest in in the December 2020 quarter at 320.16M. The Enterprise Value was at its lowest in in the September 2020 quarter at 17.50K.

TriSalus Life Sciences, Inc. (TLSI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TriSalus Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TriSalus Life Sciences, Inc. (TLSI) Average Enterprise Value

How has TLSI Enterprise Value performed in the past?

The current Enterprise Value of TriSalus Life Sciences, Inc. (TLSI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

TriSalus Life Sciences, Inc. (TLSI) Enterprise Value vs. Peers

How is TLSI’s Enterprise Value compared to its peers?

TriSalus Life Sciences, Inc.’s Enterprise Value is greater than Profound Medical Corp. (171.18M), greater than MaxCyte, Inc. (173.73M), greater than Perspective Therapeutics, Inc. (152.35M), greater than Anteris Technologies Global Corp. (123.77M), greater than Prenetics Global Limited (173.30M), greater than LENSAR, Inc. (131.23M), greater than Nano-X Imaging Ltd. (202.26M), greater than Owlet, Inc. (216.84M), greater than Neuronetics, Inc. (89.91M), less than Armata Pharmaceuticals, Inc. (315.49M),

Build a custom stock screener for TriSalus Life Sciences, Inc. (TLSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TriSalus Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TriSalus Life Sciences, Inc. (TLSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TriSalus Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.